Skip to Main Navigation Skip to Content
Collaborative global initiatives in science

Main Content

Poster Presentations

The following Poster Presentations were featured at The Macrae Foundation’s XIV International Symposium on Respiratory Viral Infections. They represent significant research in the field of respiratory viral infections and reflect topics covered at the meeting.


P – 1 Hani’ah Abdullah Modulation of ‘Cough Receptor’ Expression in Fundamental Cell Types of Human Airways Following Rhinovirus Infection
P – 2 Ghassan Al-Mousa The Reassortment of Neuraminidase (NA) Gene of Influenza A (H3N2) Virus across eight years (2000 – 2007) in Western Australia
P – 3 Wladimir J. Alonso Exceptionally High Mortality Rate of the 1918 Influenza Pandemic in the Brazilian Naval Fleet
P – 4 Wladimir J. Alonso Public Preparedness Guidance for a Severe Influenza Pandemic in 10 Countries: Qualitative Assessment and Critical Overview
P – 5 Ayse Basak Altas Influenza and Other Respiratory Viruses Surveillance During 2011-2012 Season In Turkey: Mid Season Evaluation
P – 6 Nancy Otieno Awuor Demographic, Socioeconomic and Geographic Determinants of Seasonal Influenza Vaccine Uptake in Rural Western Kenya, 2011
P – 7 Gisela Barrera Badillo Virological Surveillance of Influenza and Others Respiratory Viruses Circulating in Mexico during 2011
P – 8 Fatma Bayrakdar Investigation of other Respiratory Viruses during 2010-2011 Influenza Surveillance Season in Turkey
P – 9 Robert Booy Impacts on Influenza A(H1N1)pdm09 Infection from Cross-protection of Seasonal Trivalent Influenza Vaccines and A(H1N1)pdm09 Vaccines: Systematic Review and Meta-analyses
P – 10 Robert Booy An Unblinded Randomized Study of Influenza A (H1N1) 2009 Resistance under Standard and Double Dose Oseltamivir Treatment: Better Outcome for the Patient or the Virus?
P – 11 Tatiane Karen Cabeca Tomazella Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 10 years among Different Brazilian Populations
P – 12 Clarice Neves Camargo Human Rhinovirus Genotyping in Samples of Immunocompetent and Immunocompromissed Patients with Suspicion Respiratory Viral Infection
P – 13 Won Suk Choi Effectiveness of 2010-2011 Seasonal Influenza Vaccine for Preventing Laboratory-confirmed Influenza Infection in Korea
P – 14 Byung Chul Chun Perception, Vaccination and Preventive Behaviors on Pandemic Influenza A (H1N1) 2009 – Comparison between High Risk Groups and Non-high Risk Groups in Korea
P – 15 Byung Chul Chun Climate Factors and Incidence of Influenza-Like Illness during 2005~2008 in Korea
P – 16 Jean Marie Cohen FLURESP: A New European Commission Project Assessing Cost-effectiveness of European Influenza Human Pandemic Response Strategies
P – 17 Jean Marie Cohen EFG Junior Cohort: Parts of an Economical Analysis of the Burden of p(H1N1)09 Influenza among Children
P – 18 Regina Dutkowski Susceptibility of Influenza B Infections to Oseltamivir: Findings from the first 3 years of the Influenza Resistance Information Study (IRIS)
P – 19 Regina Dutkowski Effectiveness of Oseltamivir in Adults and Adolescents with Seasonal Influenza taking Symptomatic Therapy: a Retrospective Analysis of RCT Data
P – 20 Eman Abd Elkreem Outpatient Surveys to Assess How Representative Egypt’s Sentinel Surveillance System for Influenza-Like Illness Was Before and During the H1N1 Pandemic, 2009
P – 21 Eman Abd Elkreem Prevalence of Pandemic A (H1N1) Infection among Pilgrims Returning to a Country where Pre-Departure Vaccination against Pandemic A (H1N1) was Required—Egypt 2009
P – 22 Andrew Flatt PCR Assessing the Burden and Significance of Rhinovirus in Immunosuppressed Paediatric Patients at Great Ormand Street Hospital for Children
P – 23 Louis Fries Immunogenicity of a Recombinant RSV F Protein Nanoparticle Vaccine Manufactured in Insect Cells: Induction of Palivizumab-like Activity
P – 24 George Gachara Maina Comparison of Selection Pressures on the Haemagglutinin (HA) Gene of Pandemic (2009) and Seasonal Influenza A Viruses in Kenya
P – 25 George Gachara Maina Sequence Analysis of the Neuraminidase (NA) Gene of Pandemic H1N1 Influenza A Virus in Kenya
P – 26 Natasha Halasa Utility of a RSV Rapid Diagnostic Assay in Hospitalized Children in Amman, Jordan
P – 27 Kulziya Imanculova The Improvement of Diagnostics and Treatment of Persistent Infection in Children with Chronic Nonspecific Bronchopulmonary Diseases
P – 28 Gabriela Ispas Complete Inhibition of RSV Shedding in Vervet Monkeys Treated with a Small Molecule Fusion Inhibitor
P – 29 Kaliya Kasymbekova The Etiology of Respiratory and Enteric Pathogens of Children under four years age with SARI in the Kyrgyz Republic
P – 30 Benjawan Khuntirat Subclinical or Mild Pandemic Influenza A (H1N1) Virus Infections among Adults in Rural Thailand
P – 31 Surender Khurana Correlates Of Antibody Mediated Protection Against Pandemic Influenza: Role Of Antibody Specificity And Affinity Maturation In Homologous And Heterologous Protection
P – 32 Kyung Hyun Kim Structures of Monomeric Hemagglutinin and its Complex with an Fab Fragment of a Neutralizing Antibody that Binds to H1 Subtype Influenza Viruses
P – 33 Kyun-Hwan Kim Molecular and Functional Characterization of 1918 Influenza A Virus PB1-F2 Protein
P – 34 Zeynep A. Kocer Assessment of DBA/2J Mice as a Suitable Animal Model to Determine the Pathogenicity of Avian H1N1 Influenza A Viruses in Mammals
P – 35 Thomas R. Kreil A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
P – 36 Robert Lambkin-Williams Manflu: “I told you I was ill”
P – 37 Lincoln Lau A Systematic Review and Meta-analysis of 209 Pandemic Influenza A(H1N1) Household Transmission Studies
P – 38 Chang Kyu Lee Clinical Features and Genetic Diversity of Human Rhinoviruses Isolated from Hospitalized Patients in Seoul
P – 39 Chae Seung Lim Evaluation of five Influenza Rapid Diagnostic Kits for Influenza A/B Virus
P – 40 Viktor Lozitsky Proteolysis Inhibitor E-Aminocaproic Acid is Effective Drug for Prevention and Treatment of Influenza and other Acute Respiratory Viral Infections in Children and Adults
P – 41 Viktor Lozitsky Anti-influenza Action of Calluses from Tobacco-plants
P – 42 Elizabeth Macias and Victor MacIntosh United States (US) Department of Defense (DoD) Global, Laboratory-Based Influenza Surveillance Program at the US Air Force School of Aerospace Medicine (USAFSAM)
P – 43 Phillip Monk ‘Proof of Concept’ Studies Supporting the Development of Inhaled Interferon Beta for the Treatment of Severe Viral Lung Infections
P – 44 Jack Nguyen Targeting Host Factors as Therapeutics for Influenza and Other Viral Diseases
P – 45 Mbayame N. Niang Immunogenicity of Trivalent Inactivated Influenza Vaccine among Rural Senegalese Children
P – 46 Kalys Nogoibaeva Severe Acute Respiratory Infection with Diarrhea Syndrome Based on the Materials from the Kyrgyz Republic, Bishkek, November 2010 – March 2011
P – 47 Ji Yun Noh Clinical Experience of Intravenous Peramivir in Hospitalized Patients with Influenza
P – 48 Gauhur Nukenova Sentinel Surveillance of Influenza Like Illnesses (ILI) in the Republic of Kazakhstan, 2008-2011
P – 49 Juliette Oxford The Study of Influenza Quarantine: Living the Experiment
P – 50 Mila M. Prill Evaluation of TaqMan Array Card for Detection of Respiratory Viruses in Children
P – 51 Tammi Ranalli Comparative Analysis of a Novel Multiplex Influenza A& B Assay with Cell Culture and DFA on Human Clinical Specimens from the 2011 Respiratory Season
P – 52 Craig Rayner The Pharmacokinetics and Safety of Oseltamivir in Infants <1 year with Influenza
P – 53 Hugo Razuri Novel Human Coronaviruses as a cause of Influenza-like Illness at the Community Level in Peru
P – 54 Paola Cristina Resende Epidemiological and Molecular Patterns of Influenza A/H1N1p Infections in Brazil: Findings from the Pandemic and Post-pandemic Periods
P – 55 Paola Cristina Resende Molecular Characterization of Influenza Viruses in South, Southeast and Northeast Brazil, 2011
P – 56 Kirill Sharshov Avian and Human Influenza Virus Surveillance in Asian part of Russia (2010-2011)
P – 57 John Tamerius Performance of a POC Fluorescent Immunoassay for Influenza A and B versus Culture and PCR
P – 58 Melis Kanturvardar Tutenyurd Respiratory Virus Detections by Multiplex RT-PCR in 2011-2012 Season
P – 59 Tomas Vega Monitoring the Intensity of Influenza Epidemics with the Moving Epidemic Method
P – 60 Timo Vesikari Immunogenicity and Safety of Seasonal Influenza Vaccination Following H1N1 Vaccination in Children and Adolescents aged 6 months to 17 years
P – 61 Peter Wark Defective Asthmatic Innate Immune Responses to Rhinovirus are not Further Impaired by Preventing Signaling through MDA-5 and TLR-3
P – 62 Maya Williams Population-based Active Surveillance for Influenza-like Illness in the Northern Peruvian Amazon